Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Themis Medicare

Sector: Healthcare | Industry: Drugs & Pharma
R 253.70 11.95  | 4.94% -23.12% - 229.52
NSE Price: Oct 14, 15:32 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 14, 15:32 253.70 11.95 4.94% 242.00 241.75 4,126 242.00 - 253.80
BSE Oct 14, 15:41 256.00 11.00 4.49% 254.80 245.00 1,191 250.00 - 256.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 6,509 P/B: 1.58 NSE Code: THEMISMED
52-Week Range: R 138.30 - 439.00 Dividend Yield: 0.00% BSE Code: 530199
TTM EPS: R -11.15 Book Value: R 158.23 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Themis Medicare -26.09 35.66 28.04 -22.71 -26.18 13.13 6.64
S&P BSE Small Cap -13.15 -0.93 -7.15 -7.45 -1.23 3.77 5.64
S&P BSE Healthcare -12.72 -6.94 -5.50 -15.31 -9.36 -2.37 10.68
Company's return has been calculated on basis of BSE's price.
As on Oct 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -12.29 -7.53 -1.19
Net Profit -250.87 -194.95 -237.03
EPS -195.13 -184.90 -229.68
Book Value -6.46 25.43 20.72
Average
Operating Margin 2.69 10.85 13.09
Net Margin -6.99 1.26 2.55
Return on Networth -8.00 3.53 8.57
Return on Investment -1.25 6.73 8.87
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - 1.74 -
Operating Profit - 72.26 -
Net Profit - 6,579.49 -
EPS - 499.89 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Themis Medicare 229.52 184.99 -10.24 -5.46 -8.00 1.58 -
Astrazeneca Pharma India 5,470.13 771.42 69.56 8.84 20.03 17.08 78.64
Eris Lifesciences 5,935.35 1,005.70 303.64 29.29 28.96 4.81 19.55
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 01, 2019 DINESH S PATEL  Buy Inheritance 163,996 295.00 483.79
Dec 02, 2017 Dr Dinesh S Patel  Buy Preferential Offer 31,250 552.70 172.72
Dec 02, 2017 Dr Sachin D Patel  Buy Preferential Offer 31,250 552.70 172.72
Dec 02, 2017 Jayshree D Patel  Buy Preferential Offer 31,250 552.70 172.72
Dec 02, 2017 Reena S Patel  Buy Preferential Offer 31,250 552.70 172.72
Fund Houses invested in the stock
Fund Sep-13 Jun-13 Mar-13 Dec-12 Sep-12
Nippon India Mutual Fund 3.327 4.426 4.426 4.477 4.444
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Themis Medicare Ltd.

Address: Plot No 69 A, G I D C Industrial Estate, Vapi, Valsad Dist, Gujarat - 396195

Email: [email protected]

Website: http://www.themismedicare.com/

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
2.13
Piotroski F-Score
3
Modified C-Score
4
5-Years Price to Earnings
Not applicable
5-Years Price to Book
1.55
Earnings Yield
EBIT / Enterprise value
0.08%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,170.35 -1.31%
Caplin Point Laboratories R402.05 +0.59%
Eris Lifesciences R432.25 +1.02%
FDC R160.15 -1.84%
JB Chemicals & Pharma R359.50 -0.26%
Laurus Labs R319.90 -2.04%
Strides Pharma Science R338.50 +4.35%
Sun Pharma Adv. Research R118.85 +2.59%
Suven Life Sciences R258.20 +0.12%
Wockhardt R253.70 +1.20%
As on Oct 14, 15:32